231 related articles for article (PubMed ID: 24347920)
1. Cholinesterase inhibitors from botanicals.
Ahmed F; Ghalib RM; Sasikala P; Ahmed KK
Pharmacogn Rev; 2013 Jul; 7(14):121-30. PubMed ID: 24347920
[TBL] [Abstract][Full Text] [Related]
2. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
4. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
[TBL] [Abstract][Full Text] [Related]
5. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
Jasiecki J; Wasąg B
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
[No Abstract] [Full Text] [Related]
6. Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update.
Loizzo MR; Tundis R; Menichini F; Menichini F
Curr Med Chem; 2008; 15(12):1209-28. PubMed ID: 18473814
[TBL] [Abstract][Full Text] [Related]
7. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Lane RM; Potkin SG; Enz A
Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
[TBL] [Abstract][Full Text] [Related]
8. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitory activity of isoquinoline alkaloids from three Cryptocarya species (Lauraceae).
Wan Othman WNN; Liew SY; Khaw KY; Murugaiyah V; Litaudon M; Awang K
Bioorg Med Chem; 2016 Sep; 24(18):4464-4469. PubMed ID: 27492195
[TBL] [Abstract][Full Text] [Related]
10. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.
Greig NH; Utsuki T; Yu Q; Zhu X; Holloway HW; Perry T; Lee B; Ingram DK; Lahiri DK
Curr Med Res Opin; 2001; 17(3):159-65. PubMed ID: 11900310
[TBL] [Abstract][Full Text] [Related]
11. Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease.
Orhan IE
Curr Med Chem; 2012; 19(14):2252-61. PubMed ID: 22414107
[TBL] [Abstract][Full Text] [Related]
12. Honey as the Potential Natural Source of Cholinesterase Inhibitors in Alzheimer's Disease.
Baranowska-Wójcik E; Szwajgier D; Winiarska-Mieczan A
Plant Foods Hum Nutr; 2020 Mar; 75(1):30-32. PubMed ID: 31925635
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin.
Kumar S
Indian J Pharmacol; 2015; 47(4):444-6. PubMed ID: 26288480
[TBL] [Abstract][Full Text] [Related]
15. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.
Piccardi M; Congiu D; Squassina A; Manconi F; Putzu PF; Mereu RM; Chillotti C; Del Zompo M
Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):895-9. PubMed ID: 17503475
[TBL] [Abstract][Full Text] [Related]
17. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.
Naik RS; Hartmann J; Kiewert C; Duysen EG; Lockridge O; Klein J
J Pharm Pharm Sci; 2009; 12(1):79-85. PubMed ID: 19470293
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines.
Basiri A; Abd Razik BM; Ezzat MO; Kia Y; Kumar RS; Almansour AI; Arumugam N; Murugaiyah V
Bioorg Chem; 2017 Dec; 75():210-216. PubMed ID: 28987876
[TBL] [Abstract][Full Text] [Related]
19. Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer's Disease.
Okello EJ; Mather J
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326457
[TBL] [Abstract][Full Text] [Related]
20. Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.
Konrath EL; Passos Cdos S; Klein LC; Henriques AT
J Pharm Pharmacol; 2013 Dec; 65(12):1701-25. PubMed ID: 24236981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
